• For Researchers

Thinking outside the chromosome – how ecDNA is challenging conventional thinking

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study? What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?

11 November 2022

• Health & Medicine

6 highlights from our Black in Cancer conference

Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start. Many cancers affect Black people differently. Often, their outcomes are worse. There's a long way to go to change that, but this is how we can start.

31 October 2022

• Health & Medicine

How the history of medicine influenced our perception of cancer

From the language we use to talk about cancer, to the cancer types that receive the most funding, there’s a lot that we don’t realise has been hugely influenced by the past From the language we use to talk about cancer, to the cancer types that receive the most funding, there’s a lot that we don’t realise has been hugely influenced by the past

13 October 2022

• For Researchers

Excellence in cancer research nursing: Celebrating innovation during tough times

We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials... We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials...

7 October 2022

• For Researchers

A cut above: Making drug discovery more efficient using CRISPR

CRISPR-Cas9 is a world-renowned genome editing tool, but much of the hype has been focused on direct clinical applications. However, there is clear potential for utilising the system in functional genomic screens to develop new cancer medicines... CRISPR-Cas9 is a world-renowned genome editing tool, but much of the hype has been focused on direct clinical applications. However, there is clear potential for utilising the system in functional genomic screens to develop new cancer medicines...

16 August 2022

• Health & Medicine

Help seeking: Why isn’t it as simple as it might sound?

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

10 August 2022

• Personal Stories

Investing in volunteers since 2002: The tale of time

This is the story of time. Of minutes and days which turn into months and years. The story of our 33,000 time-givers. This is the story of time. Of minutes and days which turn into months and years. The story of our 33,000 time-givers.

11 July 2022

• For Researchers

Joining the dots: How our new research data strategy will unlock the power of big data

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help

7 July 2022

• Policy & Insight

Making real change: 4 ways we’ve influenced cancer policy

From restricting sunbed use for under 18s, to banning smoking at work and in public places, here are 4 ways we’ve influenced cancer policy and made real change. From restricting sunbed use for under 18s, to banning smoking at work and in public places, here are 4 ways we’ve influenced cancer policy and made real change.

6 July 2022